$Humacyte (HUMA.US)$The New York Times article is hurting the stock. Did Humacyte conceal flaws in its product? Reddit comments vary. Hoping to hear a response from the company.
1
1
Report
Analyst 五代雄介
:
the article dr lee working for competitor’s company, nothing to worry about. it is a FDA approved product, time will tell
$Humacyte (HUMA.US)$ Humacyte Announces Issuance of U.S. Patent Covering Manufacturing of Symvess™ and Other Bioengineered Tissues Humacyte (Nasdaq: HUMA) has been granted U.S. Patent No. 12,195,711 for its 'Drawer System for Cultivating Tissue,' covering key aspects of their bioreactor manufacturing system until 2040. The patent specifically relates to the production of Symvess, their first-in-class bioengineered human tissue designed as a universally implantable vascular conduit. The compa...
3
1
Report
72839823
:
The trend went up only few days after the patent approval. Then, it’s been going down.
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Humacyte Stock Forum
does this guy know something we dont ?
Humacyte Announces Issuance of U.S. Patent Covering Manufacturing of Symvess™ and Other Bioengineered Tissues
Humacyte (Nasdaq: HUMA) has been granted U.S. Patent No. 12,195,711 for its 'Drawer System for Cultivating Tissue,' covering key aspects of their bioreactor manufacturing system until 2040. The patent specifically relates to the production of Symvess, their first-in-class bioengineered human tissue designed as a universally implantable vascular conduit.
The compa...
No comment yet